These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 34771681)

  • 21. Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.
    Deng G; Herrler M; Burgess D; Manna E; Krag D; Burke JF
    Breast Cancer Res; 2008; 10(4):R69. PubMed ID: 18687126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).
    Weller P; Nel I; Hassenkamp P; Gauler T; Schlueter A; Lang S; Dountsop P; Hoffmann AC; Lehnerdt G
    PLoS One; 2014; 9(12):e113706. PubMed ID: 25479539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients.
    Koch C; Joosse SA; Schneegans S; Wilken OJW; Janning M; Loreth D; Müller V; Prieske K; Banys-Paluchowski M; Horst LJ; Loges S; Peine S; Wikman H; Gorges TM; Pantel K
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32069934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A microfluidic device for differential capture of heterogeneous rare tumor cells with epithelial and mesenchymal phenotypes.
    Wang X; Deng L; Gjertsen BT
    Anal Chim Acta; 2020 Sep; 1129():1-11. PubMed ID: 32891378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EpCAM-independent capture of circulating tumor cells with a 'universal CTC-chip'.
    Chikaishi Y; Yoneda K; Ohnaga T; Tanaka F
    Oncol Rep; 2017 Jan; 37(1):77-82. PubMed ID: 27840987
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin.
    Po JW; Roohullah A; Lynch D; DeFazio A; Harrison M; Harnett PR; Kennedy C; de Souza P; Becker TM
    J Circ Biomark; 2018; 7():1849454418782617. PubMed ID: 30013673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A FACS-based novel isolation technique identifies heterogeneous CTCs in oral squamous cell carcinoma.
    Chauhan A; Pal A; Sachdeva M; Boora GS; Parsana M; Bakshi J; Verma RK; Srinivasan R; Chatterjee D; Maitra A; Ghoshal S
    Front Oncol; 2024; 14():1269211. PubMed ID: 38469233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection of circulating tumour cells in patients with epithelial ovarian cancer by a microfluidic system.
    Rao Q; Zhang Q; Zheng C; Dai W; Zhang B; Ionescu-Zanetti C; Lin Z; Zhang L
    Int J Clin Exp Pathol; 2017; 10(9):9599-9606. PubMed ID: 31966837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
    Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
    PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of PD-L1 expression on circulating tumour cells in small-cell lung cancer.
    Acheampong E; Abed A; Morici M; Spencer I; Beasley AB; Bowyer S; Asante DB; Lomma C; Lin W; Millward M; Gray ES
    Transl Lung Cancer Res; 2022 Mar; 11(3):440-451. PubMed ID: 35399573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device.
    Galletti G; Sung MS; Vahdat LT; Shah MA; Santana SM; Altavilla G; Kirby BJ; Giannakakou P
    Lab Chip; 2014 Jan; 14(1):147-56. PubMed ID: 24202699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High purity microfluidic sorting and analysis of circulating tumor cells: towards routine mutation detection.
    Autebert J; Coudert B; Champ J; Saias L; Guneri ET; Lebofsky R; Bidard FC; Pierga JY; Farace F; Descroix S; Malaquin L; Viovy JL
    Lab Chip; 2015 May; 15(9):2090-101. PubMed ID: 25815443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of therapeutic efficacy with CytoSorter
    Zheng W; Zhang Y; Guo L; Wang S; Fang M; Mao W; Lou J
    Cancer Manag Res; 2019; 11():5857-5869. PubMed ID: 31303792
    [No Abstract]   [Full Text] [Related]  

  • 34. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular profiling of circulating tumor cells predicts clinical outcome in head and neck squamous cell carcinoma.
    Tada H; Takahashi H; Kuwabara-Yokobori Y; Shino M; Chikamatsu K
    Oral Oncol; 2020 Mar; 102():104558. PubMed ID: 32044652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Status of Circulating Tumor Cells in Head and Neck Squamous Cell Carcinoma: A Review.
    Aktar S; Baghaie H; Islam F; Gopalan V; Lam AK
    Otolaryngol Head Neck Surg; 2023 May; 168(5):988-1005. PubMed ID: 36939466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of a novel microfluidic platform for the isolation of rare single cells to enable CTC analysis from head and neck squamous cell carcinoma patients.
    Stiefel J; Freese C; Sriram A; Alebrand S; Srinivas N; Sproll C; Wandrey M; Gül D; Hagemann J; Becker JC; Baßler M
    Eng Life Sci; 2022 May; 22(5):391-406. PubMed ID: 35573135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epithelial-Mesenchymal Transition Status of Circulating Tumor Cells Is Associated With Tumor Relapse in Head and Neck Squamous Cell Carcinoma.
    Tada H; Takahashi H; Ida S; Nagata Y; Chikamatsu K
    Anticancer Res; 2020 Jun; 40(6):3559-3564. PubMed ID: 32487658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of circulating tumor cells with podoplanin expression in patients with locally advanced or metastatic head and neck squamous cell carcinoma.
    Hsieh JC; Lin HC; Huang CY; Hsu HL; Wu TM; Lee CL; Chen MC; Wang HM; Tseng CP
    Head Neck; 2015 Oct; 37(10):1448-55. PubMed ID: 24844673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hierarchical integration of DNA nanostructures and NanoGold onto a microchip facilitates covalent chemistry-mediated purification of circulating tumor cells in head and neck squamous cell carcinoma.
    Sun N; Zhang C; Wang J; Yue X; Kim HY; Zhang RY; Liu H; Widjaja J; Tang H; Zhang TX; Ye J; Qian A; Liu C; Wu A; Wang K; Johanis M; Yang P; Liu H; Meng M; Liang L; Pei R; Chai-Ho W; Zhu Y; Tseng HR
    Nano Today; 2023 Apr; 49():. PubMed ID: 38037608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.